Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer
- Resource Type
- Article
- Source
- In
Bioorganic & Medicinal Chemistry 15 August 2023 91 - Subject
- Language
- ISSN
- 0968-0896